|
Time on waiting list (per year)
|
1.27
|
1.00-1.62
|
0.05*
|
1.62
|
1.07–1.78
|
0.02*
|
|
Creatinine (per 10 μmol/l)
|
1.03
|
1.01–1.06
|
0.01*
|
1.07
|
1.03–1.11
|
<0.001*
|
|
LVH
|
3.78
|
1.12–12.72
|
0.03*
|
6.23
|
1.18–22.31
|
0.004*
|
|
Male
|
0.43
|
0.19–0.98
|
0.04*
|
0.23
|
0.11–0.65
|
0.02*
|
|
LAV/BSA above 32.1 ml/m2
|
3.11
|
1.27–7.57
|
0.01*
|
6.60
|
1.70–18.58
|
0.02*
|
|
Delayed graft function
|
2.42
|
1.08–5.64
|
0.03
|
3.12
|
1.02–9.57
|
0.05*
|
|
Cerebrovascular disease
|
6.76
|
2.58–17.78
|
0.05*
|
3.12
|
0.91–23.7
|
0.07
|
|
Peripheral vascular disease
|
3.36
|
1.00–11.37
|
0.05*
|
7.38
|
0.51–52.3
|
0.21
|
|
Age at transplantation (per year)
|
1.04
|
1.00–1.08
|
0.05*
|
1.02
|
0.96–1.26
|
0.43
|
|
BMI (per kg/m2)
|
1.02
|
0.94–1.12
|
0.69
| | | |
|
Biopsy-proven acute rejection
|
2.76
|
0.37–5.68
|
0.21
| | | |
|
LVSD
|
2.38
|
0.88–6.47
|
0.08
| | | |
|
Ischemic heart disease
|
1.33
|
0.45–3.91
|
0.61
| | | |
|
LV dilation
|
1.16
|
0.34–3.90
|
0.82
| | | |
|
Diabetes mellitus
|
0.59
|
0.25–1.31
|
0.19
| | | |
|
Heart failure
|
0.86
|
0.12–6.40
|
0.88
| | | |
|
Current/Ex smoker (ref never)
|
1.58
|
0.67–3.72
|
0.30
| | | |
|
Systolic BP (per mmHg)
|
1.02
|
0.99–1.04
|
0.15
| | | |
|
Diastolic BP (per mmHg)
|
0.98
|
0.94–1.02
|
0.26
| | | |
|
Dyslipidemia
|
1.67
|
0.71–3.99
|
0.24
| | | |
|
RRT time to CMR (years)
|
0.92
|
0.81–1.05
|
0.21
| | | |
|
Previous RRT type
| | | | | | |
|
PD
|
1.00
| | | | | |
|
HD
|
1.29
|
0.17–9.79
|
0.80
| | | |
|
Hemoglobin (per g/dl)
|
0.65
|
0.97–1.13
|
0.13
| | | |
|
Albumin (per g/l)
|
0.83
|
0.65–1.05
|
0.13
| | | |
|
Phosphate (per mmol/l)
|
0.43
|
0.07–2.75
|
0.37
| | | |
|
Calcium (per mmol/l)
|
5.45
|
0.11–12.54
|
0.40
| | | |
|
ACEI/ARB therapy pre-transplant
|
0.52
|
0.16–1.76
|
0.29
| | | |
|
ACEI/ARB therapy post-transplant
|
0.42
|
0.10–1.80
|
0.24
| | | |
